Dilute Betadine Lavage in the Prevention of Postoperative Infection



Status:Recruiting
Conditions:Infectious Disease, Orthopedic
Therapuetic Areas:Immunology / Infectious Diseases, Orthopedics / Podiatry
Healthy:No
Age Range:18 - 90
Updated:6/10/2018
Start Date:August 2010
End Date:December 2019
Contact:Darren R Plummer, BBA, MBA
Email:darren.plummer@rushortho.com
Phone:312-432-2468

Use our guide to learn which trials are right for you!

Efficacy of a Dilute Betadine Lavage in the Prevention of Postoperative Infection in Revision Total Knee Arthroplasty

The purpose of this study is to examine the efficacy of a dilute betadine solution in
reducing infectious complications in revision total knee arthroplasty. The investigators will
enroll patients who are scheduled to undergo a revision total knee arthroplasty. Patients
will be randomized into two groups. The treatment group will receive a dilute betadine lavage
prior to surgical closure for 3 minutes followed by 2000ml of sterile saline irrigation and
the control group will receive the 2000ml sterile saline lavage alone.

Infections in total knee arthroplasty are still a major source of morbidity and mortality in
Orthopaedics. They often necessitate long term antibiotics, reoperation, and can lead to
further complications such as sepsis or even death. Infection prevention remains one of the
primary goals of an orthopedic surgeon. While most sources report the infection rate for
primary total knee arthroplasty to be less than 1%, the reported rate for infection in
revision total knee arthroplasties has been reported to be as high as 5.6%. Despite steps
taken towards infection prevention such as proper administration of preoperative antibiotics,
strict adherence to sterile methods, and meticulous sterile preparation of the surgical site;
infection remains higher in the total knee revision arthroplasty patient population when
compared to primary total knee arthroplasty. A dilute betadine lavage (0.35% to 1% povidone
iodine) prior to surgical closure has been shown in general surgical procedures as well as
orthopaedic spine surgeries to reduce the infection rate in their patients, but this has not
been examined in total joint arthroplasty.

The study will enroll patients who are scheduled to undergo a revision total knee
arthroplasty. Patients will be randomized into two groups. The treatment group will receive a
dilute betadine lavage prior to surgical closure for 3 minutes followed by 2000ml of sterile
saline irrigation and the control group will receive the 2000ml sterile saline lavage alone.
All other treatment will be standard of care.

Subjects will then be followed for one year post surgery for infection, as defined by
Appendix 1, at intervals of 2 weeks, 6 weeks, 3 months, and one year from the date of
surgery. During these visits patients will receive standard post operative care which
includes infection screening. If an infection is clinically suspected with symptoms such as
warmth and erythema over the joint, reduced mobility of the joint, and increasing pain at the
joint, then infection data will be collected which will consist of a Erythrocyte
Sedimentation Rate, C-Reactive Protein levels and a synovial fluid sample will be taken for
white blood cell count and bacterial culture.

Inclusion Criteria:

- Scheduled to undergo revision total knee arthroplasty

Exclusion Criteria:

- Inability to provide informed consent or to comply with study assessments (e.g. due to
cognitive impairment or geographic distance).

- Age ≤ 17.

- Allergy to povidone iodine.

- Any condition requiring antibiotics 14 days prior to arriving for surgery.

- Patients with chronic immunosuppression (such as HIV/AIDS).

- Unable to adhere to follow up schedule and treatment.

- Patients scheduled to undergo revision total knee arthroplasty for infectious reasons.
We found this trial at
2
sites
Winfield, Illinois 60190
Principal Investigator: Scott Sporer, MD
?
mi
from
Winfield, IL
Click here to add this to my saved trials
1653 W. Congress Parkway
Chicago, Illinois 60612
(312) 942-5000
Principal Investigator: Craig J Della Valle, MD
Rush University Medical Center Rush University Medical Center encompasses a 664-bed hospital serving adults and...
?
mi
from
Chicago, IL
Click here to add this to my saved trials